LGND logo

LGND Accounts payable

annual accounts payable:

$5.23M+$2.81M(+115.62%)
December 31, 2024

Summary

  • As of today (May 25, 2025), LGND annual accounts payable is $5.23 million, with the most recent change of +$2.81 million (+115.62%) on December 31, 2024.
  • During the last 3 years, LGND annual accounts payable has fallen by -$3.17 million (-37.72%).
  • LGND annual accounts payable is now -72.23% below its all-time high of $18.84 million, reached on December 31, 2003.

Performance

LGND Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDbalance sheet metrics

quarterly accounts payable:

$5.37M+$133.00K(+2.54%)
March 31, 2025

Summary

  • As of today (May 25, 2025), LGND quarterly accounts payable is $5.37 million, with the most recent change of +$133.00 thousand (+2.54%) on March 31, 2025.
  • Over the past year, LGND quarterly accounts payable has increased by +$3.47 million (+183.47%).
  • LGND quarterly accounts payable is now -73.47% below its all-time high of $20.23 million, reached on June 30, 2004.

Performance

LGND quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

LGND Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+115.6%+183.5%
3 y3 years-37.7%-23.0%
5 y5 years+116.2%+59.5%

LGND Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-37.7%+115.6%-72.0%+199.3%
5 y5-year-37.7%+116.2%-72.0%+199.3%
alltimeall time-72.2%+131.7%-73.5%+436.6%

LGND Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$5.37M(+2.5%)
Dec 2024
$5.23M(+115.6%)
$5.23M(+11.5%)
Sep 2024
-
$4.69M(+161.8%)
Jun 2024
-
$1.79M(-5.3%)
Mar 2024
-
$1.89M(-22.0%)
Dec 2023
$2.43M(-54.3%)
$2.43M(-1.9%)
Sep 2023
-
$2.48M(-74.2%)
Jun 2023
-
$9.58M(+56.2%)
Mar 2023
-
$6.13M(+15.6%)
Dec 2022
$5.31M(-36.8%)
$5.31M(-66.6%)
Sep 2022
-
$15.89M(-17.1%)
Jun 2022
-
$19.15M(+174.7%)
Mar 2022
-
$6.97M(-17.0%)
Dec 2021
$8.40M(+122.1%)
$8.40M(+16.2%)
Sep 2021
-
$7.23M(-58.1%)
Jun 2021
-
$17.27M(+82.4%)
Mar 2021
-
$9.47M(+150.2%)
Dec 2020
$3.78M(+56.4%)
$3.78M(-62.8%)
Sep 2020
-
$10.17M(+66.6%)
Jun 2020
-
$6.10M(+81.4%)
Mar 2020
-
$3.37M(+39.0%)
Dec 2019
$2.42M(-42.1%)
$2.42M(+18.6%)
Sep 2019
-
$2.04M(-29.4%)
Jun 2019
-
$2.89M(-42.9%)
Mar 2019
-
$5.06M(+21.0%)
Dec 2018
$4.18M(+85.2%)
$4.18M(+154.0%)
Sep 2018
-
$1.65M(-38.6%)
Jun 2018
-
$2.68M(-21.3%)
Mar 2018
-
$3.41M(+50.8%)
Dec 2017
$2.26M(-17.4%)
$2.26M(-37.5%)
Sep 2017
-
$3.62M(+101.1%)
Jun 2017
-
$1.80M(-72.1%)
Mar 2017
-
$6.46M(+136.1%)
Dec 2016
$2.73M(-33.0%)
$2.73M(-0.8%)
Sep 2016
-
$2.76M(+18.0%)
Jun 2016
-
$2.34M(-13.1%)
Mar 2016
-
$2.69M(-34.2%)
Dec 2015
$4.08M(-47.0%)
$4.08M(+29.9%)
Sep 2015
-
$3.14M(+16.1%)
Jun 2015
-
$2.71M(-63.6%)
Mar 2015
-
$7.44M(-3.3%)
Dec 2014
$7.70M(+94.8%)
$7.70M(+58.3%)
Sep 2014
-
$4.86M(-3.9%)
Jun 2014
-
$5.06M(+37.7%)
Mar 2014
-
$3.67M(-7.0%)
Dec 2013
$3.95M(-32.5%)
$3.95M(-8.2%)
Sep 2013
-
$4.30M(-9.5%)
Jun 2013
-
$4.75M(-13.9%)
Mar 2013
-
$5.52M(-5.7%)
Dec 2012
$5.85M(-47.1%)
$5.85M(-2.9%)
Sep 2012
-
$6.03M(-10.7%)
Jun 2012
-
$6.75M(-14.5%)
Mar 2012
-
$7.89M(-28.7%)
Dec 2011
$11.06M(+28.7%)
$11.06M(+9.9%)
Sep 2011
-
$10.07M(-5.2%)
Jun 2011
-
$10.63M(-18.4%)
Mar 2011
-
$13.03M(+51.6%)
Dec 2010
$8.60M(-49.3%)
$8.60M(-24.2%)
Sep 2010
-
$11.34M(-15.7%)
Jun 2010
-
$13.45M(-7.4%)
Mar 2010
-
$14.52M(-14.3%)
Dec 2009
$16.95M
$16.95M(+17.8%)
DateAnnualQuarterly
Sep 2009
-
$14.38M(-3.1%)
Jun 2009
-
$14.84M(-5.1%)
Mar 2009
-
$15.64M(+6.9%)
Dec 2008
$14.63M(+15.3%)
$14.63M(+62.3%)
Sep 2008
-
$9.01M(-12.4%)
Jun 2008
-
$10.29M(-4.4%)
Mar 2008
-
$10.76M(-15.2%)
Dec 2007
$12.68M(+3.5%)
$12.68M(+21.4%)
Sep 2007
-
$10.45M(-4.5%)
Jun 2007
-
$10.94M(-17.0%)
Mar 2007
-
$13.18M(+7.5%)
Dec 2006
$12.26M(-20.2%)
$12.26M(-23.8%)
Sep 2006
-
$16.08M(-17.4%)
Jun 2006
-
$19.46M(+19.2%)
Mar 2006
-
$16.32M(+6.3%)
Dec 2005
$15.36M(-11.5%)
$15.36M(+56.6%)
Sep 2005
-
$9.81M(-31.3%)
Jun 2005
-
$14.28M(-2.1%)
Mar 2005
-
$14.59M(-15.9%)
Dec 2004
$17.35M(-7.9%)
$17.35M(+3.8%)
Sep 2004
-
$16.72M(-17.3%)
Jun 2004
-
$20.23M(+19.9%)
Mar 2004
-
$16.87M(-10.5%)
Dec 2003
$18.84M(+57.3%)
$18.84M(+9.2%)
Sep 2003
-
$17.26M(+59.5%)
Jun 2003
-
$10.82M(-19.5%)
Mar 2003
-
$13.44M(+12.2%)
Dec 2002
$11.98M(+122.5%)
$11.98M(+24.0%)
Sep 2002
-
$9.66M(-3.6%)
Jun 2002
-
$10.03M(+42.6%)
Mar 2002
-
$7.03M(+30.6%)
Dec 2001
$5.38M(+40.7%)
$5.38M(+21.9%)
Sep 2001
-
$4.42M(+7.5%)
Jun 2001
-
$4.11M(+5.7%)
Mar 2001
-
$3.89M(+1.6%)
Dec 2000
$3.83M(-29.1%)
$3.83M(-14.1%)
Sep 2000
-
$4.46M(-12.0%)
Jun 2000
-
$5.07M(+5.0%)
Mar 2000
-
$4.82M(-10.7%)
Dec 1999
$5.40M(-56.5%)
$5.40M(-1.8%)
Sep 1999
-
$5.50M(-27.6%)
Jun 1999
-
$7.60M(+7.0%)
Mar 1999
-
$7.10M(-42.7%)
Dec 1998
$12.40M(+15.9%)
$12.40M(+125.5%)
Sep 1998
-
$5.50M(-24.7%)
Jun 1998
-
$7.30M(+78.0%)
Mar 1998
-
$4.10M(-61.7%)
Dec 1997
$10.70M(+161.0%)
$10.70M(+197.2%)
Sep 1997
-
$3.60M(+12.5%)
Jun 1997
-
$3.20M(-8.6%)
Mar 1997
-
$3.50M(-14.6%)
Dec 1996
$4.10M(+5.1%)
$4.10M(+141.2%)
Sep 1996
-
$1.70M(-29.2%)
Jun 1996
-
$2.40M(+41.2%)
Mar 1996
-
$1.70M(-56.4%)
Dec 1995
$3.90M(+69.6%)
$3.90M(+85.7%)
Sep 1995
-
$2.10M(+110.0%)
Mar 1995
-
$1.00M(-56.5%)
Dec 1994
$2.30M
$2.30M(+91.7%)
Sep 1994
-
$1.20M(-7.7%)
Jun 1994
-
$1.30M(+30.0%)
Mar 1994
-
$1.00M

FAQ

  • What is Ligand Pharmaceuticals Incorporated annual accounts payable?
  • What is the all time high annual accounts payable for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated annual accounts payable year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated quarterly accounts payable year-on-year change?

What is Ligand Pharmaceuticals Incorporated annual accounts payable?

The current annual accounts payable of LGND is $5.23M

What is the all time high annual accounts payable for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high annual accounts payable is $18.84M

What is Ligand Pharmaceuticals Incorporated annual accounts payable year-on-year change?

Over the past year, LGND annual accounts payable has changed by +$2.81M (+115.62%)

What is Ligand Pharmaceuticals Incorporated quarterly accounts payable?

The current quarterly accounts payable of LGND is $5.37M

What is the all time high quarterly accounts payable for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high quarterly accounts payable is $20.23M

What is Ligand Pharmaceuticals Incorporated quarterly accounts payable year-on-year change?

Over the past year, LGND quarterly accounts payable has changed by +$3.47M (+183.47%)
On this page